Gsk Share Discussion Threads

[alphorn] 27/2/2021 12:36

Yes, Tagamet was a SKB product and Zantac's superior marketing, especially in the US, made it (Zantac) a world No1 by 1987. A classic study.

[meijiman] 27/2/2021 12:30

That's a good point. Often its not the originator but the follower who makes the big reward. I used to know this story back to front but as I recall Glaxo improved an existing product made by someone else....possibly something to do with the dosage.
I think it became the worlds biggest revenue grossing drug and laid the foundations for the global company of today. The consumer side came out of the tie up with Smith Kline Beecham.

[alphorn] 27/2/2021 12:21

He was a smart guy - it also makes a classic study on the risk/rewards of fast followers.
(Very apt on the current vaccine topic).

[meijiman] 27/2/2021 12:13

Yes it someone called Paul Girolami who made Glaxo the giant that it became. Took an ulcer drug and improved it..became a world leader product (Zantac). The cashflow from that was phenomenal. Not sure what he would make of the present ceo.

[alphorn] 27/2/2021 11:31

#159. Disagree with 'zero to do with the board', particularly with this industry. Group direction and the science to follow are key. Close to home here the push to bring Zantac to the market behind Tagamet makes a classic study. That was no accident.

[netcurtains] 27/2/2021 11:25

Spud: I doubt he's done a stellar job. Any rise in the share price has more or less zero to do with board. They are all over paid charlies in every company. We need more worker directors like the germans.

[spud] 27/2/2021 11:07

Net - Pascal Soriot was privately educated and has done a pretty stellar job!

spud

[meijiman] 27/2/2021 11:04

I can see where you are coming from. I see this particular ceo as being appointed for PC reasons.
I have had plenty of dealings with ceo's ..many have struck me as having borderline personality disorders. But I could write a book on that.
Notwithstanding the split I believe this company should be managed by someone with a strong pharmaceuticals background. A bubbly personality and relentless optimism might get you the top job, but in reality it gives you a poor skillset to run a multinational.

[netcurtains] 27/2/2021 10:05

meijiman: ceos have little or no affect on share prices. Its market forces.
Ask any small investor we all think the same - directors are all miles and miles over paid useless lot.
ceos used to make money by sacking everyone in UK and off shoring to third world.
To my mind that was not a good ceo - that is a national disgrace. Lets hope women dont ruin UK PLC like the men did.
Gut feeling is private school men see everyone else as cannon fodder. Dont let any privately educated men anywhere near a board room again.

[meijiman] 27/2/2021 09:43

Yes the bad news is that the ceo is not up to it..........

[netcurtains] 27/2/2021 09:36

Watfordhornet: Its a fall of 600 since its 2020 high.

That 600 is 50% of the current share price 1200!!!

Normally there would be some really bad bit of news to warrant a
fall of such MEGA proportions.

[watfordhornet] 27/2/2021 09:28

Ha - I know it's a drop but long way from having to do that

[roybel] 27/2/2021 09:24

At what stage do they have to release official news stating the reasons behind such a massive drop in share price ?

[royalalbert] 27/2/2021 08:46

Bought more yesterday, will carry on buying, looking to the future.

[coxsmn] 27/2/2021 08:33

Refer to the appendix slide pg 46 that accompanied the FY Results, it details out the costs and savings associated with the Separation Preparation Programme and the costs associated to prepare the Consumer business to operate as a stand alone.These are alongside other restructuring programmes that are also ongoing. In short, total charges related to the Separate Preparation Programme are expected to be £2.4bn (of which £1.5bn are cash payments). This programme is expected to achieve £800m in annual savings. The programme to ready the Consumer business for Separation includes one off charges of £600m (all of which are cash payments).

[careful] 26/2/2021 21:01

If the cost of split is $3bn and it saves $500m p.a. it is great business to do it.

Annual dividend costs that much, debt is cheap, cash flow high.
Think of it as an annuity paying 16% p.a.

They should have done it years ago, for once Woodford was correct.
the present business had become too cumbersome.

[mister md] 26/2/2021 18:58

Don't know why, but added more to holding today ...

[abdullla] 26/2/2021 18:54

Every body has a handicap mine is just taking the mickey for fun,yours is telling lies to satisfy your fantasies about owning,selling and shorting shares with perfect timings,whatever stay happy!

[abdullla] 26/2/2021 17:50

Sorry I cannot help it I just get a kick out of it !

[montyhedge] 26/2/2021 17:39

Keep taking the medication, I hope it's from GSK.It's a risk off day in the market. Have you seen the FTSE 100,reason US bond rise.They paid down debt 20% if you read the rns. We just had 23p dividend we got another 80p next 12 months, I hope they fall to 1150p next week, fill my boots.

[abdullla] 26/2/2021 17:09

God forbid!

[netcurtains] 26/2/2021 17:02

abdulla: Do you see the 'winding up' this year? Perhaps by the summer? Or earlier?

[abdullla] 26/2/2021 17:01

In the pecking order debt has to be paid first,in the current situation there will not be anything left for the share holders.

[watfordhornet] 26/2/2021 16:55

EW is - getting loads of free shares so of course she is holding

[abdullla] 26/2/2021 16:48

It will be sad to see this British jewel in the pharmas crown go to administration.